These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16230890)

  • 21. Effects of long-term iloprost treatment on right ventricular function in patients with Eisenmenger syndrome.
    Chon MK; Cho KI; Cha KS; Seo JS; Kim DS
    J Cardiol; 2017 May; 69(5):741-746. PubMed ID: 27492657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy.
    Tay EL; Papaphylactou M; Diller GP; Alonso-Gonzalez R; Inuzuka R; Giannakoulas G; Harries C; Wort SJ; Swan L; Dimopoulos K; Gatzoulis MA
    Int J Cardiol; 2011 Jun; 149(3):372-6. PubMed ID: 20304507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
    D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
    Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug combination treatment for pulmonary arterial hypertension].
    Ghofrani HA; Hoeper MM
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S330-3. PubMed ID: 17139600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic effect of iloprost inhalation and oral sildenafil during acute vasoreactivity test in pulmonary arterial hypertension.
    Sompradeekul S; Wattanasiriphakdee S
    J Med Assoc Thai; 2015 Feb; 98(2):144-9. PubMed ID: 25842794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iloprost inhalation for the treatment of severe persistent pulmonary hypertension of the newborn, experience at QSNICH.
    Chotigeat U; Champrasert M; Khorana M; Sangtaweesin V; Kanjanapattanakul W
    J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S89-94. PubMed ID: 25391178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension.
    Stiebellehner L; Petkov V; Vonbank K; Funk G; Schenk P; Ziesche R; Block LH
    Chest; 2003 Apr; 123(4):1293-5. PubMed ID: 12684325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide.
    Michelakis E; Tymchak W; Lien D; Webster L; Hashimoto K; Archer S
    Circulation; 2002 May; 105(20):2398-403. PubMed ID: 12021227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined treatment of sildenafil and inhaled iloprost in pediatric patients with severe pulmonary arterial hypertension].
    Santos-Martínez LE; Jiménez-Santos M; Arenas-Fonseca JG; Moreno-González A; Medina-Concebida LE
    Arch Cardiol Mex; 2015; 85(1):80-4. PubMed ID: 25576259
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful switch from long-term intravenous iloprost to non-invasive combination therapy in idiopathic pulmonary arterial hypertension.
    Halank M; Kolditz M; Opitz C; Hoeffken G; Ewert R
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):54-9. PubMed ID: 16489527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combination therapy in patients with pulmonary arterial hypertension].
    Ewert R; Opitz CF; Schäper C; Gläser S
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S187-90. PubMed ID: 18814093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of inhaled iloprost on exercise capacity, quality of life, and cardiac function in patients with pulmonary arterial hypertension secondary to congenital heart disease (the Eisenmenger syndrome) (from the EIGER Study).
    Cha KS; Cho KI; Seo JS; Choi JH; Park YH; Yang DH; Hong GR; Kim DS
    Am J Cardiol; 2013 Dec; 112(11):1834-9. PubMed ID: 24012036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dyspnea in Eisenmenger syndrome and its amelioration by sildenafil: role of J receptors.
    Anand A; Srivastava N; Barwad P; Ramakrishnan S; Roy A; Bhargava B
    Int J Cardiol; 2014 Jul; 174(3):574-8. PubMed ID: 24820738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single-centre, placebo-controlled, double-blind randomised cross-over study of nebulised iloprost in patients with Eisenmenger syndrome: A pilot study.
    Nashat H; Kempny A; Harries C; Dormand N; Alonso-Gonzalez R; Price LC; Gatzoulis MA; Dimopoulos K; Wort SJ
    Int J Cardiol; 2020 Jan; 299():131-135. PubMed ID: 31371115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The management of adult female patients with Eisenmenger syndrome and advanced pulmonary arterial hypertension treatment: single center experience and follow-up for 5 years].
    Taçoy G; Başer HD; Türkoğlu S; Cengel A
    Turk Kardiyol Dern Ars; 2014 Sep; 42(6):531-41. PubMed ID: 25362943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of sildenafil in Eisenmenger's syndrome secondary to atrial septal defect versus ventricular septal defect: a cardiac catheterisation follow-up study.
    Garg N; Tripathy N; Sinha N
    Cardiol Young; 2011 Dec; 21(6):631-8. PubMed ID: 21729508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled iloprost for severe persistent pulmonary hypertension of the newborn.
    Chotigeat U; Jaratwashirakul S
    J Med Assoc Thai; 2007 Jan; 90(1):167-70. PubMed ID: 17621749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Goal-oriented treatment and combination therapy for pulmonary arterial hypertension.
    Hoeper MM; Markevych I; Spiekerkoetter E; Welte T; Niedermeyer J
    Eur Respir J; 2005 Nov; 26(5):858-63. PubMed ID: 16264047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sildenafil use in patients with the Eisenmenger syndrome.
    Rosenthal E
    Circulation; 2004 Apr; 109(16):e197; author reply e197. PubMed ID: 15117867
    [No Abstract]   [Full Text] [Related]  

  • 40. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
    Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.